Targeting cereblon in AML

Blood. 2021 Feb 4;137(5):584-586. doi: 10.1182/blood.2020009827.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Lenalidomide
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Stem Cells
  • Thalidomide
  • Ubiquitin-Protein Ligases*

Substances

  • Thalidomide
  • Ubiquitin-Protein Ligases
  • Lenalidomide